Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Dawson R, Diacon AH, Variava E, Moloantoa T, et al. Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial. Lancet Infect Dis 2026 May 29:S1473-3099(26)00143.
PMID: 42214407


Privacy Policy